News|Articles|February 8, 2019

Mixing Dynamics Adds Italvacuum Equipment

Mixing Dynamics has been selected as North American representative for Italvacuum dryers and pumps.

Mixing Dynamics, Commack, NY, announced in a Feb. 1, 2019 press release that the company has been named as representative for the sales and service of vacuum dryers and vacuum pumps manufactured by Italvacuum of Turin, Italy.

Italvacuum, manufactures double cone vacuum dryers, horizontal paddle-type vacuum dryers, and vacuum tray dryers for the fine chemical and pharmaceutical industries and manufactures the Saurus line of piston-type vacuum pumps.

“The decision to select Mixing Dynamics was mainly due to their highly technical approach to sales and marketing and their existing line-up of European partners that have already been represented extremely well in North America by Mixing Dynamics,” said Dario Penco, Italvacuum’s export manager, in the press release.

“Adding Italvacuum to our portfolio of World-Class European partners further elevates our reputation for providing exceptional service and marketing resources on behalf of our partners and to our clients in North America,” said Doug Cohen, president of Mixing Dynamics in the announcement.

Source: Mixing Systems

 

 


Related to this article

Trophy and confetti on light background, top view with space for text. Victory concept | Image Credit: ©New Africa -stock.adobe.com
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 1
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.